✦ LIBER ✦

The Cost Effectiveness of Long-Acting/Extended-Release Antipsychotics for the Treatment of Schizophrenia

✍ Scribed by Achilla, Evanthia; McCrone, Paul

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Injectable Atypica

✍ Hemels, M.; Einarson, T.R.; Zilbershtein, R.; Schubert, A.; Skrzekowska-Baran, I 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Cost-Effectiveness of Second-Generation

✍ Park, Taehwan; Kuntz, Karen M. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 622 KB

2967 – Long-acting injectable antipsycho

✍ Fleischhacker, W.W. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 French ⚖ 31 KB

Long-acting injectable formulations of a

✍ Eun Ji Park, Sarmila Amatya, Myung Sun Kim… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 250 KB

PMH34 Long-Term Cost-Effectiveness of At

✍ K. Rajagopalan; K. O'Day; K. Meyer; A.A. Pikalov iii; A. Loebel 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

C.04.03 Relevance of study design for th

✍ Correll, C. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 68 KB